{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:31:10Z","timestamp":1787319070784,"version":"build-2736575974"},"reference-count":16,"publisher":"Georg Thieme Verlag KG","issue":"06","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Perinatol"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This study aimed to increase the rate of low-dose aspirin (LDA) counseling and treatment in patients with two or more moderate risk factors for preeclampsia (PMRF) from 9 to 50% within a 4-month period after implementation of interventions.<\/jats:p>\n                  <jats:p>A single-institution quality improvement initiative aimed at LDA screening and counseling of those with PMRF. Two groups were evaluated: Preintervention (January\u2013April 2022) and postintervention (January\u2013April 2023). This initiative focused on identifying PMRF and monitoring rates of LDA counseling and treatment. Rates were assessed at 2-week intervals and presented on a run chart to visualize trends and measure progress over time. Providers underwent education utilizing preeclampsia (PEC) screening flowsheets and integrated a clinical decision-making (CDM) tool in initial prenatal visit documentation using a smart tool. Patients were provided with educational flyers.<\/jats:p>\n                  <jats:p>In the preintervention group (n\u2009=\u2009126), 8.7% of patients received counseling on PMRF risk factors and LDA use, and 7.9% were treated with LDA. In the postintervention group (n\u2009=\u2009112), 52.7% of patients received counseling on PMRF risk factors and LDA use, and 35.7% were treated with LDA. There was an 83.5% increase in the percentage of patients counseled following intervention implementation. A progressive increase was noted in counseling rates within the 18 weeks postintervention.<\/jats:p>\n                  <jats:p>Integrating PEC screening flowsheets, CDM tools, and patient education flyers effectively enhances LDA counseling for patients with two or more PMRFs, with additional benefits seen in high-risk patients. These interventions offer a replicable model to enhance guideline adherence and reduce PEC risk in vulnerable populations.<\/jats:p>","DOI":"10.1055\/a-2681-6377","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T23:00:02Z","timestamp":1755039602000},"page":"729-735","source":"Crossref","is-referenced-by-count":3,"title":["A Quality Improvement Initiative to Optimize Low-Dose Aspirin Use in Patients with Moderate Risk Factors for Preeclampsia"],"prefix":"10.1055","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7298-0302","authenticated-orcid":false,"given":"Delphina","family":"Maldonado","sequence":"additional","affiliation":[{"name":"New York University Grossman Long Island School of Medicine, Mineola, New York, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Lenox Hill Hospital, New York, New York, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6222-1067","authenticated-orcid":false,"given":"Sebastian","family":"Geraci","sequence":"additional","affiliation":[{"name":"New York University Grossman Long Island School of Medicine, Mineola, New York, United States"},{"name":"Department of Obstetrics and Gynecology, New York University Grossman Long Island School of Medicine, Mineola, New York, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilly","family":"Drohan","sequence":"additional","affiliation":[{"name":"New York University Grossman Long Island School of Medicine, Mineola, New York, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Walker","sequence":"additional","affiliation":[{"name":"New York University Grossman Long Island School of Medicine, Mineola, New York, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiwei","family":"Yang","sequence":"additional","affiliation":[{"name":"New York University Grossman Long Island School of Medicine, Mineola, New York, United States"},{"name":"Division of Health Services Research, Department of Foundations of Medicine, New York University Grossman Long Island School of Medicine, Mineola, New York, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Divers","sequence":"additional","affiliation":[{"name":"New York University Grossman Long Island School of Medicine, Mineola, New York, United States"},{"name":"Division of Health Services Research, Department of Foundations of Medicine, New York University Grossman Long Island School of Medicine, Mineola, New York, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8307-2430","authenticated-orcid":false,"given":"Anju","family":"Suhag","sequence":"additional","affiliation":[{"name":"New York University Grossman Long Island School of Medicine, Mineola, New York, United States"},{"name":"Department of Obstetrics and Gynecology, New York University Grossman Long Island School of Medicine, Mineola, New York, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"issue":"48","key":"ref1","doi-asserted-by":"crossref","first-page":"e27916","DOI":"10.1097\/MD.0000000000027916","article-title":"Aspirin in the prevention of preeclampsia: A protocol for systematic review and meta analysis","volume":"100","author":"P Z Mkhize","year":"2021","journal-title":"Medicine (Baltimore)"},{"issue":"01","key":"ref2","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/AOG.0000000000002708","article-title":"ACOG Committee Opinion No. 743: Low-dose aspirin use during pregnancy","volume":"132","author":"American College of Obstetricians and Gynecologists","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"12","key":"ref3","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1001\/jama.2021.8551","article-title":"Aspirin use to prevent preeclampsia and related morbidity and mortality: Updated evidence report and systematic review for the US Preventive Services Task Force","volume":"326","author":"J T Henderson","year":"2021","journal-title":"JAMA"},{"issue":"12","key":"ref4","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/jama.2021.14781","article-title":"Aspirin use to prevent preeclampsia and related morbidity and mortality: US Preventive Services Task Force Recommendation Statement","volume":"326","author":"K W Davidson","year":"2021","journal-title":"JAMA"},{"issue":"01","key":"ref5","doi-asserted-by":"crossref","first-page":"e2142343","DOI":"10.1001\/jamanetworkopen.2021.42343","article-title":"Estimated prevalence of risk factors for preeclampsia among individuals giving birth in the US in 2019","volume":"5","author":"S M Wheeler","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"e2130804","DOI":"10.1001\/jamanetworkopen.2021.30804","article-title":"Use of a smartphone app to explore potential underuse of prophylactic aspirin for preeclampsia","volume":"4","author":"T Krishnamurti","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"06","key":"ref7","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1055\/s-0040-1718580","article-title":"Improving utilization of aspirin for prevention of preeclampsia in a high-risk urban cohort: a prospective cohort study","volume":"38","author":"R C Boelig","year":"2021","journal-title":"Am J Perinatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e1120","DOI":"10.1055\/a-1990-2728","article-title":"Physician's knowledge and practices surrounding low-dose aspirin for preeclampsia risk reduction","volume":"41","author":"L C Martinez-King","year":"2024","journal-title":"Am J Perinatol"},{"issue":"03","key":"ref9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ajog.2022.11.1302","article-title":"Association of checklist usage with adherence to recommended prophylactic low-dose aspirin for prevention of preeclampsia","volume":"228","author":"M K Zhou","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e89S","DOI":"10.1378\/chest.11-2293","article-title":"Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"J W Eikelboom","year":"2012","journal-title":"Chest"},{"issue":"04","key":"ref12","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ajog.2023.04.031","article-title":"Low-dose aspirin therapy for the prevention of preeclampsia: time to reconsider our recommendations?","volume":"229","author":"R Horgan","year":"2023","journal-title":"Am J Obstet Gynecol"},{"issue":"02","key":"ref13","doi-asserted-by":"crossref","first-page":"e2457828","DOI":"10.1001\/jamanetworkopen.2024.57828","article-title":"Prophylactic aspirin dose and preeclampsia","volume":"8","author":"E Kupka","year":"2025","journal-title":"JAMA Netw Open"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e2410","DOI":"10.1055\/s-0043-1771260","article-title":"Efficacy and safety of aspirin 162\u2009mg for preeclampsia prophylaxis in high-risk patients","volume":"41","author":"M Ayyash","year":"2024","journal-title":"Am J Perinatol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e2004","DOI":"10.1055\/a-2096-3466","article-title":"Factors associated with guideline concordant clinician counseling about low-dose aspirin to prevent preeclampsia in nulliparous patients","volume":"41","author":"S O Myers","year":"2024","journal-title":"Am J Perinatol"},{"issue":"05","key":"ref16","doi-asserted-by":"crossref","first-page":"100663","DOI":"10.1016\/j.ajogmf.2022.100663","article-title":"Assessment of adherence to aspirin for preeclampsia prophylaxis and reasons for nonadherence","volume":"4","author":"D N Olson","year":"2022","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"06","key":"ref17","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1097\/AOG.0000000000003581","article-title":"Maternal and infant health care costs related to preeclampsia","volume":"134","author":"J Hao","year":"2019","journal-title":"Obstet Gynecol"}],"container-title":["American Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2681-6377.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T22:35:15Z","timestamp":1775860515000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2681-6377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":16,"journal-issue":{"issue":"06","published-online":{"date-parts":[[2026,4,10]]},"published-print":{"date-parts":[[2026,4]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2681-6377","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0735-1631","1098-8785"],"issn-type":[{"value":"0735-1631","type":"print"},{"value":"1098-8785","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8,12]]},"published":{"date-parts":[[2025,8,12]]}}}